Biology of Hepatic Encephalopathy. School of Medicine Division of Transplantation Immunology & Mucosal Biology MRC Centre for Transplantation
|
|
- Silvia Wiggins
- 6 years ago
- Views:
Transcription
1 Biology of Hepatic Encephalopathy School of Medicine Division of Transplantation Immunology & Mucosal Biology MRC Centre for Transplantation
2 Pavlov s Physiology Factory 1904: Nobel Prize for developing the concept of the conditional reflex in which he trained a dog to salivate to the sound of a bell. Hepatic Encephalopathy was first described by Ivan Pavlov and Marcel Nencki over 120 years ago at the Imperial Institute of Experimental Medicine in Russia.
3 Serendipity Surgically created a portacaval shunt in a dog (Eck-Pavlov Shunt) Diverting blood away from the portal vein to the IVC Developed behavioural symptoms 10 days 6 weeks following surgery Nencki M, Pawlow J & Zaleski J (1896). Ueber den ammoniakgehalt des blutes under der organe und die harnstoffbildung bei den saugethieren. Archiv fuer experimentelle pathologie und pharmakologie 37,
4 Meat Intoxication Syndrome Aggression Irritability Ataxia Convulsions Coma This was exacerbated by eating red meat but not by milk or bread. Nencki M, Pawlow J & Zaleski J (1896). Archiv fuer experimentelle pathologie und pharmakologie 37,
5 Nitrogen Balance Studies Increased ammonium salts in urine. Arterial ammonia rose x 3-4 approaching that normally found in the portal vein following a protein meal. Increased urinary excretion of ammonia following a protein meal. Brain ammonia content was x4 that of normal. Ammonia administration orally or iv Developed behavioural symptoms Coma & Death
6 Ammonia is central in the pathogenesis of Hepatic Encephalopathy µmol/l Olde Damink et al. Neurochem. Int. 2001
7 Almost all organs are involved in ammonia metabolism Urea Ammonia Glutamine Urea
8 Ammonia metabolism in cirrhosis Urea Ammonia Glutamine Urea Muscle plays an important role in ammonia metabolism in cirrhosis
9 How does the ammonia affect the brain? Patients with liver dysfunction have impaired urea synthesis. The brain acts as an alternative ammonia detoxification pathway. Astrocytes are star-shaped cells that provide physical and nutritional support for neurons. Converting ammonia to glutamine.
10 Ammonia-glutamine-brain swelling hypothesis ASTROCYTE GLUTAMATE NH 3 GLUTAMINE Ammonia H 2 0 H 2 0 GLUTAMINE H 2 0 H 2 0 H 2 0 Astrocyte swelling & increased brain water
11 Myo-inositol is an important osmotic regulator within the astrocyte Ammonia H 2 0 Myo-inositol Glutamine Low myo-inositol levels in the brain are associated with neuropsychological deterioration Shawcross et al. Am J Physiol 2004
12 Pathogenesis of Cerebral Oedema NH 3 Hepatocellular necrosis and apoptosis Inflammatory Mediators (e.g. NO) Astrocyte swelling ICP Cerebral Blood Flow
13 Acute Liver Failure Cerebral Oedema and Intracranial Hypertension.. the most feared complication of ALF.. Blei, Hepatology 2000;32:
14 Cerebral Ammonia and Risk of Cerebral Herniation Clemmeson et al. Hepatology 1999
15 Incidence of Intracranial Hypertension in 3300 patients at King s over 35 years Clinical Evidence of Intracranial Hypertension. All ALF, n= % Developing ICH Bernal et al. J Hepatol Error bars are 95% CI. p<
16 In cirrhosis, hepatic encephalopathy is a neuropsychiatric syndrome associated with low grade brain oedema Poor concentration Psychomotor dysfunction Impaired memory Sensory abnormalities Increased reaction time Cordoba et al. The development of low-grade cerebral oedema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities which reverse after liver transplantation. J of Hepatol. 2001
17 More than just ammonia? In practice the correlation between the arterial ammonia concentration and the clinical manifestation of encephalopathy in cirrhosis is often poor. We now recognise infection as being a common precipitant of encephalopathy.
18 Delirium: Hepatic versus Septic Encephalopathy Recognition of the association between systemic infection and impaired brain function dates back to Hippocrates >2500 years ago. Hepatic Septic Sepsis-related encephalopathy arises from the action of inflammatory mediators on the brain or a cytotoxic response by brain cells to these mediators.
19 Astrocytes are part of the macrophage lineage Astrocytes have a huge repertoire of cytokine responses. Nitric oxide, free radicals, prostanoids & proinflammatory cytokines. Inflammation may modulate the effects of ammonia on the brain.
20 Evidence for the role of inflammation in Hepatic Encephalopathy: ALF Mortality SIRS Score Rolando observed a rapid progression in the severity of HE in those patients with ALF that have more marked inflammation (SIRS). (Rolando et al. Hepatology 2000). In a study from the US ALF group, progression of HE from mild to deeper stages was temporally associated with the development of infection, especially in those with acetaminophen-induced ALF. (Vaquero et al. Gastroenterology 2003).
21 In patients with cirrhosis, there is mounting evidence for the role of SIRS in exacerbating the symptoms of HE Minimal Grade 1-4 Coma Clinical Studies Shawcross et al. J. Hepatol Shawcross et al. Metabolic Brain Dis Shawcross & Sharifi J. Hepatol Montoliu et al. Am. J of Gastroenterol Animal Studies Willard et al. Exp. Brain Res Tanaka et al. J Neurosci Res Marini & Broussard. Mol. Genet. Metab Jover et al. Hepatology 2006 Cauli et al. Hepatology 2007 Wright et al. Hepatology 2007
22 Endotoxemia produces coma & brain oedema in BDL rats HD (ammonia fed) rats had significantly raised frontal brain water compared to: Sham p=0.001 BDL p= Significant increase in brain water in all groups treated with LPS. Wright G, Davies N et al. Hepatology 2007
23 Significant increase in brain nitrotyrosine was seen in the BDL rats treated with LPS only Ammonia and LPS cause nitrosation of proteins in the brain and act as an important pathway in producing alteration in the mental state. Nitrotyrosine is formed from the reaction between ammonia and peroxynitrite; peroxynitrite being formed from the interaction of increased astroglial NO with superoxide. Wright G, Davies N et al. Hepatology 2007
24 Systemic Inflammation, Ammonia and the Blood Brain Barrier LPS NH 3 Neutrophil Cytokine Cerebral Blood Flow Granules (Myeloperoxidase) Microbial Pathogen Microglia Shawcross et al. Hepatology 2010
25 Rajiv Jalan Gut Liver Brain Axis
26 Precipitating Factors Overt Hepatic Encephalopathy Normal Ammonia Load (TIPSS; constipation; GI bleeding) Infection Endotoxemia (Bacterial translocation) Hyponatremia Dehydration/Diarrhoea Renal Dysfunction Metabolic Alkalosis Sedative Drugs e.g. benzodiazepines
27 Therapeutic Overview Strategies of Therapies in HE L-Ornithine L- Aspartate Ornithine Phenylacetate Glycerol Phenylbutyrate Flumazenil Dopamine Agonists Minocycline Anti-cholinesterases Hypothermia NSAIDs Anti-TNFα Lactulose Rifaximin [Neomycin/Vancomycin] Norfloxacin Probiotics AST 120 beads [Protein Restriction] Hemodialysis Hemofiltration Fluid Expansion
28 Encephalopathy and the Kidney
29 Summary Ammonia is central in the pathogenesis of hepatic encephalopathy. The understanding of inter-organ ammonia metabolism is key in the design of ammonialowering therapies. Inflammation and infection modulate the cerebral effects of ammonia. Future therapies are likely to target the generation of systemic and cerebral inflammation in the development of encephalopathy.
30 THANK YOU Dr Debbie Shawcross Senior Lecturer and Honorary Consultant in Hepatology Institute of Liver Studies King s College London
Hepatic Encephalopathy
Hepatic Encephalopathy John Barber UMassMedical Student, Class of 2019 www.12daysinmarch.com Outline Overview Normal Physiology Pathology Symptoms Diagnosis Treatment Overview Ammonia (NH 3 ) is a byproduct
More informationThe Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present:
The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present: Certified by: Provided by: Endorsed by: Hepatic Encephalopathy Hepatic Encephalopathy:
More informationNew Developments in the Management of Acute Liver Failure. Oren Fix, MD, MSc, FACP Assistant Professor of Medicine Division of Gastroenterology
New Developments in the Management of Acute Liver Failure Oren Fix, MD, MSc, FACP Assistant Professor of Medicine Division of Gastroenterology Learning Objectives Describe 3 new approaches to the management
More informationHepatic Encephalopathy A 2016 perspective Rajiv Jalan UCL Institute for Liver and Digestive Health Royal Free Hospital
Malaga 2016 Hepatic Encephalopathy A 2016 perspective Rajiv Jalan UCL Institute for Liver and Digestive Health Royal Free Hospital Disclosures (Rajiv Jalan): Inventor: Ornithine phenyl acetate for the
More informationManagement of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL
Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Terminology Acute decompensation of cirrhosis - stable patient with sudden deterioration Acute-on-chronic liver failure
More informationComplications of Cirrhosis
Complications of Cirrhosis Causes of Cirrhosis Alcohol Chronic Viral Hepatitis (B/C) Haemochromatosis Autoimmune Hepatitis NAFLD/NASH Primary Biliary Cirrhosis Primary Sclerosing Cholangitis 1-AT deficiency
More informationPACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in
More informationDrug-Induced Liver Injury and Hepatic Encephalopathy
Drug-Induced Liver Injury and Hepatic Encephalopathy William M. Lee, MD Division of Digestive and Liver Diseases UT Southwestern Medical Center at Dallas Division of Gastroenterology, Hepatology and Nutrition
More informationInnovative Therapeutics for Orphan Liver Disease
Innovative Therapeutics for Orphan Liver Disease Note Regarding Forward-Looking Statements Certain statements in this presentation constitute forward-looking statements within the meaning of the Securities
More informationThis educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website.
Date of preparation: February 2014. 4C/NIPV/0517 1 This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website. 2 Disclaimer This educational
More informationPACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in
More informationUnderstanding Hepatic Encephalopathy
Understanding Hepatic Encephalopathy / Intensive Care Medicine 1 Understanding Hepatic Encephalopathy Nicolas WEISS 1,2,3, MD, PhD, Rajiv JALAN 4, MD, PhD, and Dominique THABUT 5, MD, PhD. 1, 2, 1 Brain
More informationUPDATE ON UREA CYCLE DISORDERS TREATMENT
UPDATE ON UREA CYCLE DISORDERS TREATMENT George A. Diaz, MD, PhD Program for Inherited Metabolic Diseases Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai Disclosure
More informationUrea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training
Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic
More informationCurrent Concepts in Diagnosis and Management of Acute Liver Failure
Current Concepts in Diagnosis and Management of Acute Liver Failure Oren Fix, MD, MSc, FACP, AGAF, FAASLD Medical Director, Liver Transplant Program Swedish Medical Center Seattle, WA Learning Objectives
More informationManagement of Hepatic Encephalopathy
Management of Hepatic Encephalopathy Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH
More informationand ammonia intoxication Diseases', Bethesda, Maryland, U.S.A. in animals with liver disease produced by a variety of
Gut, 1963, 4, Liver disease KENNETH S. and ammonia intoxication WARREN AND STEVEN SCHENKER From the U.S. Department of Health, Education and Welfare, Public Health Service, National Institutes of Health,
More informationQuiz 39. This quiz is being published on behalf of the Education Committee of the SNACC. Start. Hepatic disease and neuroanesthesia
Quiz 39 Hepatic disease and neuroanesthesia SUNEETA GOLLAPUDY, M.D ASSOCIATE PROFESSOR, DIRECTOR OF NEUROANESTHESIA, MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WI QUIZ TEAM: SHOBANA RAJAN, M.D; SUNEETA GOLLAPUDY,
More informationPathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow
Journal of Hepatology 41 (2004) 613 620 www.elsevier.com/locate/jhep Pathogenesis of intracranial hypertension in acute liver failure: inflammation, and cerebral blood flow Rajiv Jalan 1,3, *, Steven W.M.
More informationRole of Interleukin 6 as a Predictor of Hepatic encephalopathy in Critically Ill Cirrhotic Patients.
Role of Interleukin 6 as a Predictor of Hepatic encephalopathy in Critically Ill Cirrhotic Mohsen Maher 1, Tarek Yossef 1, Hesham Darwesh 2, Ahmed El Saady 1 Amal I.Sabry 2, Waled A hamed 1 and Antonio
More informationA novel ammonia lowering strategy for the treatment of intracranial hypertension in acute liver failure
Faculty of Health Sciences A novel ammonia lowering strategy for the treatment of intracranial hypertension in acute liver failure Experimental studies in pigs Rune Gangsøy Kristiansen A dissertation for
More informationDialyzing challenging patients: Patients with hepato-renal conditions
Dialyzing challenging patients: Patients with hepato-renal conditions Nidyanandh Vadivel MD Medical Director for Living kidney Donor and Pancreas Transplant Programs Swedish Organ Transplant, Seattle Acute
More informationCIRCULATORY AND RENAL FAILURE IN CIRRHOSIS
CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS Pere Ginès, MD Liver Unit, Hospital Clínic Barcelona, Catalunya, Spain CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS Hecker R and Sherlock S, The Lancet 1956 RENAL
More informationWEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry
MPharm Programme Liver Biochemistry Slide 1 of 49 MPHM Liver Biochemistry Learning Outcomes Assess and evaluate the signs and symptoms of illness Assess and critically appraise a patients medication regimen,
More informationTreating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC
Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC mino.mitri@ubc.ca No Conflict of Interest 157 patients 157 patients 6 transplanted Criteria Liver
More informationMichael Tuchfarber, MD edition
Michael Tuchfarber, MD 2017 edition Review the possible mechanisms of the pathogenesis of hepatic encephalopathy Review the clinical manifestations of hepatic encephalopathy Understand how to make a diagnosis
More informationAnalysis of combined effect of synbiotic and LOLA in improving neuropsychometric function
2017; 6(5): 152-156 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 TPI 2017; 6(5): 152-156 2017 TPI www.thepharmajournal.com Received: 26-03-2017 Accepted: 27-04-2017 Preetha Nandabalan
More informationComplex neuropsychatric syndrome complicating advanced liver disease and/or portosystemic shunting (1990s) Complex neuropsychatric syndrome caused by
Complex neuropsychatric syndrome complicating advanced liver disease and/or portosystemic shunting (1990s) Complex neuropsychatric syndrome caused by portosystemic venous shunting with or without intrinsic
More informationHepatology on the AMU
Hepatology on the AMU RCP day, 8 th February 2018 Jo Leithead Consultant in Hepatology and Liver Transplantation Addenbrookes Hospital Cambridge Is liver disease relevant to me? Williams R, Lancet 2014
More informationPersistent Hyperammonemia Is Associated With Complications and Poor Outcomes in Patients With Acute Liver Failure
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:925 931 Persistent Hyperammonemia Is Associated With Complications and Poor Outcomes in Patients With Acute Liver Failure RAMESH KUMAR,* SHALIMAR,* HANISH
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Accelerated intravascular coagulation and fibrinolysis (AICF) in liver disease, 390 391 Acid suppression in liver disease, 403 404 ACLF.
More informationProfessor Peter Hayes University of Edinburgh
Professor Peter Hayes University of Edinburgh Acute liver failure BHIVA meeting, April 2018 No disclosures relevant to this presentation ALF DEFINITIONS Trey and Davidson, 1970 Potentially a reversible
More informationDrug-induced Hyperammonemia (HA)
Drug-induced hyperammonemia: are there specific therapies? NACCT Boston 2016 Florian Eyer Department of Clinical Toxicology & Poison Control Centre Munich TUM School of Medicine Technical University of
More informationLiver Disease in the ICU: Acute Liver Failure
Liver Disease in the ICU: Acute Liver Failure Steven C Pugliese, MD Assistant Professor Division of Pulmonary Sciences and Cri@cal Care Medicine University of Colorado Denver 48 y/o male w/out prior liver
More informationThere is now strong evidence of a central role for
LIVER FAILURE/CIRRHOSIS/PORTAL HYPERTENSION Arterial Ammonia and Clinical Risk Factors for Encephalopathy and Intracranial Hypertension in Acute Liver Failure William Bernal, Catherine Hall, Constantine
More informationUrea is the major end product of nitrogen catabolism in humans One nitrogen free NH3 other nitrogen aspartate. carbon oxygen CO2 liver,
Urea is the major end product of nitrogen catabolism in humans Urea is the major disposal form of amino groups derived from amino acids, and accounts about 90% percent of the nitrogencontaining components
More informationNutritional Support in Liver Diseases Topic 13
Nutritional Support in Liver Diseases Topic 13 Module 13.1 Nutritional Support in Acute Liver Failure William Bernal MD FRCP Liver Intensive Therapy Unit Institute of Liver Studies Kings College Hospital
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 Inborn Errors Of Metabolism Urea Cycle Disorders Diagnosis And Care F. Feillet (FR) Urea cycle disorders, diagnosis and care F Feillet National reference centre for Inborn errors
More informationKing s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know.
King s College Hospital NHS Foundation Trust Acute Liver Disease: what you really need to know. William Bernal Professor of Liver Critical Care Liver Intensive Therapy Unit Institute of Liver Studies Kings
More informationCognitive abnormalities in cirrhosis
AISF 2015 - Young Investigator Lecture Cognitive abnormalities in cirrhosis Sara Montagnese Disclosures I have received lecture fees from Merz Pharmaceuticals GmbH and Norgine The University of Padova
More informationTHE LIVER AND THE GUT
THE LIVER AND THE GUT Liver & Gut A quintessential relationship One does not work well without the other There is a continuous bidirectional communication between these organs through the bile, hormones,
More informationLow myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia
Am J Physiol Gastrointest Liver Physiol 287: G503 G509, 2004; 10.1152/ajpgi.00104.2004. TRANSLATIONAL PHYSIOLOGY Low myo-inositol and high glutamine levels in brain are associated with neuropsychological
More informationSlide 1 THE LIVER AND THE GUT. Slide 2 Liver & Gut. Slide 3 Gut Health For Detoxing
Slide 1 THE LIVER AND THE GUT Slide 2 Liver & Gut A quintessential relationship One does not work well without the other There is a continuous bidirectional communication between these organs through the
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationPathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies
Journal of Hepatology 39 (2003) 278 285 Review Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies Roger F. Butterworth* Neuroscience Research Unit, Hôpital Saint-Luc
More informationHEPATIC ENCEPHALOPATHY(HE) AND NUTRITIONAL SUPPORT. Jin-Woo Lee, MD,PhD. Division of Hepatology Inha University Hospital
HEPATIC ENCEPHALOPATHY(HE) AND NUTRITIONAL SUPPORT Jin-Woo Lee, MD,PhD. Division of Hepatology Inha University Hospital Contents 1. Definition and causes of HE 2. Diagnosis and treatment of HE 3. Malnutriton
More informationConflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.
Complications of end stage liver disease Conflict of interest disclosures None Amir Qamar, MD Instructor of Medicine Brigham and Women s s Hospital Harvard Medical School Boston, MA 02115 The many complications
More informationAMINO ACID METABOLISM
AMINO ACID METABOLISM Synthesis of Urea in Liver The series of reactions that form urea is known as the Urea Cycle or the Krebs-Henseleit Cycle. The urea cycle operates only to eliminate excess nitrogen.
More informationRita Garcia Martinez Juan Rodés Grupo investigación enfermedades hepáticas y digestivas Hospital General Universitario Gregorio Marañon
Rita Garcia Martinez Juan Rodés Grupo investigación enfermedades hepáticas y digestivas Hospital General Universitario Gregorio Marañon Medico especialista Medicina Interna-Hepatología H. Vall d Hebron
More informationManagement of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy
Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:
More informationStrategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis
Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Sponsored by Integrity Continuing Education, Inc. Supported by an educational Practitioner
More informationAcute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018
Acute Liver Failure Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Disclosures None Outline Overview of ALF Management of ALF Diagnosis of ALF Treatments and Support
More informationManaging Encephalopathy in the Outpatient Setting
REVIEW Managing Encephalopathy in the Outpatient Setting Sahaj Rathi, M.D., and Radha K. Dhiman, M.D., D.M., F.A.M.S., F.A.C.G., F.R.C.P., F.A.A.S.L.D. Hepatic encephalopathy (HE) refers to brain dysfunction
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationManagement of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University
Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments
More informationManagement of the Cirrhotic Patient in the ICU
Management of the Cirrhotic Patient in the ICU Peter E. Morris, MD Professor & Chief, Pulmonary, Critical Care and Sleep Medicine University of Kentucky Conflict of Interest Funding US National Institutes
More informationManagement of Cirrhosis Related Complications
Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this
More informationHepatic encephalopathy: a critical current review
https://doi.org/10.1007/s12072-017-9812-3 SPECIAL ISSUE - PORTAL HYPERTENSION Hepatic encephalopathy: a critical current review Anna Hadjihambi 1,2 Natalia Arias 1,3 Mohammed Sheikh 1 Rajiv Jalan 1 Received:
More informationLiver Failure. The most severe clinical consequence of liver disease is liver failure:
Liver diseases I The major primary diseases of the liver are: - Viral hepatitis, - Nonalcoholic fatty liver disease (NAFLD), - Alcoholic liver disease, - Hepatocellular carcinoma (HCC) Hepatic damage also
More informationAmino Acid Metabolism
Amino Acid Metabolism The continuous degradation and synthesis of cellular proteins occur in all forms of life. Each day humans turn over 1 2% of their total body protein, principally muscle protein. Approximately
More informationInterorgan ammonia metabolism in liver failure: the basis of current and future therapies
Liver International ISSN 1478-3223 REVIEW ARTICLE : the basis of current and future therapies Gavin Wright 1, Lorette Noiret 1, Steven W. M. Olde Damink 2,3 and Rajiv Jalan 1 1 Liver Failure Group, the
More informationINTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES
International Journal of Institutional Pharmacy and Life Sciences 5(5): September-October 2015 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Life Sciences Research Article!!! Received:
More informationNutrition Management of End- Stage Liver Failure
Nutrition Management of End- Stage Liver Failure Krystel Ouaijan, RDN, MSc Nutrition Support Dietitian in Saint George Hospital UMC PhD in University of Geneva Just few questions https://www.mentimeter.com/s/c1c1be18dc2
More informationKing s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre.
King s College Hospital NHS Foundation Trust NHS Acute on Chronic Liver Failure: Practical management outside the tertiary centre. William Bernal Professor of Liver Critical Care Liver Intensive Therapy
More informationUrea cycle: Urea cycle is discovered by Krebs andhanseleit(1932).
Urea cycle: Urea cycle is discovered by Krebs andhanseleit(1932). Urea cycle is the removal of excess of NH2 derived from amino acids catabolism in the tissues and excreted in urine. Site of synthesis:
More informationNew developments in Urea Cycle Disorders and its impact on patients
New developments in Urea Cycle Disorders and its impact on patients Johannes Häberle University Children s Hospital Zurich, Division of Metabolism 16 June 2015 SFEIM 2015, Lille, France The urea cycle
More informationA mmonia is a key metabolite derived from amino acid
141 LIVER Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver R Jalan, D Kapoor... Gut 23;52:141 145 See end of article for authors affiliations...
More informationPALLIATIVE CARE IN END-STAGE LIVER DISEASE
PALLIATIVE CARE IN END-STAGE LIVER DISEASE Ken S. Ota, DO Family Medicine Banner Good Samaritan Medical Center Learning Objectives: Describe the common bio-psycho-social issues in end-stage liver disease
More informationImaging ischemic strokes: Correlating radiological findings with the pathophysiological evolution of an infarct
Imaging ischemic strokes: Correlating radiological findings with the pathophysiological evolution of an infarct Jay Chyung,, PhD, HMS III Patient A: history 91 y.o. woman Acute onset R sided weakness and
More informationHEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management
HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology
More informationLiver-Kidney Crosstalk in Liver and Kidney Diseases
Liver-Kidney Crosstalk in Liver and Kidney Diseases Sundararaman Swaminathan MD Associate Professor Division of Nephrology University of Virginia Health System Charlottesville, VA Hepatonephrologist busily
More informationIJBCP International Journal of Basic & Clinical Pharmacology
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20170331 Original Research Article Effectiveness
More informationDecompensated chronic liver disease
Decompensated chronic liver disease Definition of decompensated chronic liver disease Patients with chronic liver disease can present with acute decompensation due to various causes. The decompensation
More informationContinuous Peritransplant Assessment of Consciousness using Bispectral Index Monitoring for Patients with Fulminant Hepatic Failure
Continuous Peritransplant Assessment of Consciousness using Bispectral Index Monitoring for Patients with Fulminant Hepatic Failure Purpose: Deterioration of consciousness is the most critical problem
More informationRole of Branched Chain Amino Acids in Hepatic Encephalopathy
ORIGINAL ARTICLE (APMC 378) DOI: 10.29054/APMC/17.378 Role of Branched Chain Amino Acids in Hepatic Encephalopathy Umair Ahmed, Aamir Shaukat, Hooria Aamir, Awais Ahmed ABSTRACT Introduction: Hepatic encephalopathy
More informationGastrointestinal Physiology. Intensive Care Training Program Radboud University Nijmegen Medical Centre
Gastrointestinal Physiology Intensive Care Training Program Radboud University Nijmegen Medical Centre Content Gastrointestinal blood flow Portal hypertension Motility disorders Specific metabolic disorders
More informationCauses of Liver Disease in US
Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,
More informationEDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,
More informationSystematic review with multiple treatment comparison metaanalysis. on interventions for hepatic encephalopathy
Systematic review with multiple treatment comparison metaanalysis on interventions for hepatic encephalopathy Hepatic encephalopathy (HE) is a reversible neuropsychiatric syndrome associated with severe
More informationConflicts of Interest in the last 12 months
STEATOHEPATITIS Richard K. Sterling, MD, MSc, FACP, FACG VCU Hepatology Professor of Medicine Chief, Section of Hepatology Virginia Commonwealth University Richmond, VA Conflicts of Interest in the last
More informationLuis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015
Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015 Protein-calorie malnutrition (PCM) is extremely common
More informationHepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
Drugs (2019) 79 (Suppl 1):S17 S21 https://doi.org/10.1007/s40265-018-1017-0 REVIEW ARTICLE Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology Roger F. Butterworth 1 Published online: 31
More informationThe Importance of Diagnosing Covert Hepatic Encephalopathy
The Importance of Diagnosing Covert Hepatic Encephalopathy Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council
More informationWhat Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured
What Is Cirrhosis? Cirrhosis occurs when the liver is permanently scarred or injured by chronic conditions and diseases. Common causes of cirrhosis include: Long-term alcohol abuse. Chronic viral hepatitis
More informationPharmacotherapy of hepatic encephalopathy in cirrhosis
Expert Opinion on Pharmacotherapy ISSN: 1465-6566 (Print) 1744-7666 (Online) Journal homepage: http://www.tandfonline.com/loi/ieop20 Pharmacotherapy of hepatic encephalopathy in cirrhosis Manuel Romero-Gómez
More informationHEPATIC ENCEPHALOPATHY: PATHOGENESIS, DIAGNOSIS AND MANAGEMENT
Proc. R. Coll. Physicians Edinb. 1998; 28:111-118 HEPATIC ENCEPHALOPATHY: PATHOGENESIS, DIAGNOSIS AND MANAGEMENT H.F. Lui, R. Jalan, * P.C. Hayes, Centre for Liver and Digestive Disorders and Department
More informationFormulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.
Formulations and Availability S TU D I E S PE R D I S E A S E 39 LIVER Liver Disease, Cirrhosis, Liver Failure, Hepatic Encephalopathy S TU D I E S PE R AG E G RO U P Visbiome Regular Product Code: 693-0412-01
More informationUREA CYCLE DISORDERS - The What, Why, How and When
UREA CYCLE DISORDERS - The What, Why, How and When George A. Diaz, MD, PhD Program for Inherited Metabolic Diseases Department of Genetics and Genomic Sciences Department of Pediatrics Icahn School of
More informationIntracranial Hypertension in Acute Liver Failure: Pathophysiological Basis of Rational Management
Intracranial Hypertension in Acute Liver Failure: Pathophysiological Basis of Rational Management Rajiv Jalan, M.D., FRCPE 1 ABSTRACT Increased intracranial pressure (ICP) in patients with acute liver
More informationTreatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management
Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation
More informationC -001/ ½
Nursing Management in Critical Care Conditions Assignment I (Block 1-3) (Tutor Marked) Programme Code: DCCN Course Code: BNS - 032 Assignment Code: BNS 032 /TMA -001/2019 Date of submission: July30th,
More informationJana Novotná, Bruno Sopko. Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ.
Amino acid metabolism II. Urea cycle Jana Novotná, Bruno Sopko Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ. Nitrogen balance Tissue proteins
More informationStrategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis
Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Sponsored by Integrity Continuing Education, Inc. Supported by an educational Practitioner
More informationRicky Bell Renal/ICM Registrar
Ricky Bell Renal/ICM Registrar Objectives When to call renal How to manage the patient with AKI How the manage the patient with CKD (HD/PD) Special AKI situations What do the guidelines say? My referral
More informationRoger F. Butterworth, Ph.D., D.Sc.
Roger F. Butterworth, Ph.D., D.Sc. Hepatic encephalopathy (HE) is a brain disorder caused by chronic liver failure, particularly in alcoholics with cirrhosis, which results in cognitive, psychiatric, and
More informationUNIT3 INTRODUCTION TO HEALTH CONDITIONSIPROBLEMS RELATED TO DIGESTIVE AND URINARY ORGANS
UNIT3 INTRODUCTION TO HEALTH CONDITIONSIPROBLEMS RELATED TO DIGESTIVE AND URINARY ORGANS Structures 3.0 Objectives 3.1 Introduction 3.2 Conditions Affecting Digestive System 3.2.1 Chronic Liver Failure
More informationOverview of the immune system
Overview of the immune system Immune system Innate (nonspecific) 1 st line of defense Adaptive (specific) 2 nd line of defense Cellular components Humoral components Cellular components Humoral components
More informationCONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number:
Cirrhosis Care Bundle CONTROLLED DOCUMENT CATEGORY: Clinical Guidelines CLASSIFICATION: Clinical Controlled Document CG201 Number: Version Number: 1 Controlled Document Clinical Guidelines Group Sponsor:
More informationNITROGEN METABOLISM An Overview
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL Seminar & Health Sciences NITROGEN METABOLISM
More information